logo

Merrimack Pharmaceuticals, Inc. (MACK)



Trade MACK now with
  Date
  Headline
8/3/2022 8:43:18 AM Merrimack : Ipsen Says Primary Endpoint OS Not Met In Patients Treated With Onivyde Versus Topotecan In Phase 3 Trial